Stichting GGZ Drenthe

Intellectual disability and challenging behaviour

Research activity is centred on behavioural symptoms associated with intellectual disability, with particular attention to patterns of behaviours that challenge in clinical care.

  • Behavioural disturbance
  • Psychiatric management
  • Neurodevelopmental disorders

The sponsor’s current clinical interest lies in treatment-related questions for managing persistent behavioural difficulties in people with intellectual disabilities.

Antipsychotic treatment in behavioural care

Clinical research includes the use of antipsychotic medication for behavioural symptoms, with focus on agents such as pipamperone and aripiprazole in routine psychiatric practice.

  • Pipamperone
  • Aripiprazole
  • Medication-free comparison

This area reflects interest in medication strategies for reducing disruptive behavioural presentations in vulnerable patient groups.

Psychiatry and mental health care

The sponsor is active in psychiatric research linked to behavioural symptoms, with a clinical focus grounded in mental health care for people requiring specialist support.

  • Behavioural psychiatry
  • Specialist mental health services
  • Clinical symptom management

Its research profile is closely aligned with treatment questions arising in hospital-based psychiatric and developmental care settings.

Neurodevelopmental care and specialist support services

Research interests extend to clinical problems seen in neurodevelopmental disorders, especially where behavioural dysregulation affects daily functioning and support needs.

  • Intellectual and developmental disability care
  • Support for complex behaviour
  • Specialist inpatient and outpatient care

The sponsor’s work connects behavioural treatment questions with specialist care pathways for individuals with complex developmental needs.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of pipamperone and aripiprazole for challenging behaviors in people with intellectual disabilities

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands